WHO naming stem · suffix · 831 listed names
-mab
This page was written with AI.
monoclonal antibodies (previous naming scheme)
Where it sits in a name
WHO writes the stem as -mab. So the letters mab sit at the end of the name (…mab).
All 831 names WHO lists under -mab
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 159 of 831 names appear in these lists: 142 in the US list (FDA Drugs@FDA) and 144 in the EU central list (EMA); 125 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- abrezekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- acapatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- acasunlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- acrixolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- adabrelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- adalimumabUS brands: ABRILADA, AMJEVITA, CYLTEZO, HADLIMA, HULIO, HUMIRA, HYRIMOZ, IDACIO, SIMLANDI, YUFLYMA, YUSIMRY
- adalimumab betaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- adalimumab fosimdesonideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alemtuzumab
- alemtuzumab betaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alnuctamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alomfilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alsevalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- altumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amlitelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amubarvimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anatumomab mafenatoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anbenitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anetumab corixetangloNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anetumab ravtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anifrolumabUS brands: SAPHNELOEU (central) brands: Saphnelo
- anivovetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- anselamimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ansuvimabUS brands: EBANGAEU (central) brands: none found
- anumigilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- apamistamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aprutumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aprutumab ixadotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- arcitumomabUS brands: none found
- ascrinvacumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aselizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- astegolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atezolizumabUS brands: TECENTRIQEU (central) brands: Tecentriq
- atibuclimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atidortoxumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atinumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atoltivimabEU (central) brands: none found
- atorolimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- avdoralimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- avelumabUS brands: BAVENCIOEU (central) brands: Bavencio
- avizakimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- axatilimabUS brands: NIKTIMVOEU (central) brands: none found
- azintuxizumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bafisontamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- balstilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bamlanivimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bapotulimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- barecetamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- barzolvolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- basiliximabUS brands: SIMULECTEU (central) brands: Simulect
- basiliximab sarotalocanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- batoclimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bavituximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bavunalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bebtelovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bectumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bedinvetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- befovacimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- begelomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- belantamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- belantamab mafodotinUS brands: BLENREPEU (central) brands: Blenrep
- belimumabUS brands: BENLYSTAEU (central) brands: Benlysta
- beludavimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bemarituzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- benralizumabUS brands: FASENRAEU (central) brands: Fasenra
- bentracimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- benufutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bepranemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- berlimatoxumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bermekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bersanlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bertilimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- besilesomabUS brands: none foundEU (central) brands: Scintimun
- betifisolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bevacizumab
- bevacizumab betaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bevacizumab gammaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bexmarilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bezlotoxumabUS brands: ZINPLAVAEU (central) brands: Zinplava
- bimekizumabUS brands: BIMZELXEU (central) brands: Bimzelx
- birtamimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bivatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bleselumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- blinatumomabUS brands: BLINCYTOEU (central) brands: Blincyto
- blontuvetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bococizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- boserolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- botensilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brazikumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brentuximab vedotinUS brands: ADCETRISEU (central) brands: Adcetris
- briakinumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- briquilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brodalumabUS brands: SILIQEU (central) brands: Kyntheum
- brolucizumabUS brands: BEOVUEU (central) brands: Beovu
- brontictuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- budigalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- burfiralimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cabiralizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cadonilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- camidanlumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- camidanlumab tesirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- camoteskimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- camrelizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- canakinumabUS brands: ILARISEU (central) brands: Ilaris
- cantuzumab mertansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cantuzumab ravtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- caplacizumabUS brands: CABLIVIEU (central) brands: Cablivi
- capromabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- carlumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- carotuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- casirivimabUS brands: none found
- catumaxomabUS brands: none found
- cedelizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cemiplimabUS brands: LIBTAYOEU (central) brands: Libtayo
- cendakimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cergutuzumab amunaleukinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- certolizumab pegolUS brands: CIMZIAEU (central) brands: Cimzia
- cetrelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cetuximabUS brands: ERBITUXEU (central) brands: Erbitux
- cetuximab sarotalocanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cevostamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cibisatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cifurtilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cilgavimabUS brands: none found
- cinpanemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cirevetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- citatuzumab bogatoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cixutumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clazakizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clenoliximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clesrovimabUS brands: ENFLONSIAEU (central) brands: Enflonsia
- clivatuzumab tetraxetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cobolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- codrituzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cofetuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cofetuzumab pelidotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- coltuximab ravtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- conatumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- concizumabUS brands: ALHEMOEU (central) brands: Alhemo
- coprelotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cosibelimabUS brands: UNLOXCYTEU (central) brands: none found
- crefmirlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- crefmirlimab berdoxamNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- crenezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- crizanlizumabUS brands: ADAKVEO
- crotedumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- crovalimabUS brands: PIASKYEU (central) brands: Piasky
- cudarolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cusatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dacetuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- daclizumabUS brands: ZINBRYTA
- daclizumab betaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dafsolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dafsolimab setaritoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dalotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dapirolizumab pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- daratumumabUS brands: DARZALEXEU (central) brands: Darzalex
- datopotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- datopotamab deruxtecanUS brands: DATROWAYEU (central) brands: Datroway
- daxdilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dectrekumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- demcizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- demupitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- denintuzumab mafodotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- denosumabUS brands: AUKELSO, BILDYOS, BILPREVDA, BOMYNTRA, BONCRESA, BOSAYA, CONEXXENCE, ENOBY, JUBBONTI, JUBEREQ, OSENVELT, OSPOMYV
- depatuxizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- depatuxizumab mafodotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- depemokimabUS brands: EXDENSUREU (central) brands: Exdensur
- derlotuximab biotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- detumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dinutuximabUS brands: UNITUXIN
- dinutuximab betaUS brands: none foundEU (central) brands: Qarziba
- disitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- disitamab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- divozilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- docaravimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- domvanalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- donanemabUS brands: KISUNLAEU (central) brands: Kisunla
- dorlimomab aritoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dostarlimabUS brands: JEMPERLIEU (central) brands: Jemperli
- dovanvetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dresbuxelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- drozitumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- duligotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dupilumabUS brands: DUPIXENTEU (central) brands: Dupixent
- durvalumabUS brands: IMFINZIEU (central) brands: Imfinzi
- dusigitumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- duvortuxizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ebdarokimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eblasakimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ebronucimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ecleralimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ecromeximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eculizumab
- edrecolomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- efalizumabUS brands: none found
- eldelumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elezanumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elgemtumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elipovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elotuzumabUS brands: EMPLICITIEU (central) brands: Empliciti
- elranatamabUS brands: ELREXFIOEU (central) brands: Elrexfio
- elsilimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emactuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emapalumabUS brands: GAMIFANTEU (central) brands: none found
- emerfetamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emfizatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emibetuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emicizumabUS brands: HEMLIBRAEU (central) brands: Hemlibra
- emirodatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enapotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enapotamab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enavatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- encelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enfortumab vedotinUS brands: PADCEVEU (central) brands: Padcev
- enibarcimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enlimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enlimomab pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enoblituzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enokizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enoticumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ensituximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enuzovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- envafolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- epcoritamabUS brands: EPKINLYEU (central) brands: Tepkinly
- epitumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- epitumomab cituxetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- epratuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eptinezumabUS brands: VYEPTIEU (central) brands: Vyepti
- erenumabUS brands: AIMOVIGEU (central) brands: Aimovig
- erfonrilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- erlizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ertumaxomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etaracizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etesevimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etevritamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etigilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etokimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etrolizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- evinacumabUS brands: EVKEEZAEU (central) brands: Evkeeza
- evolocumabUS brands: REPATHAEU (central) brands: Repatha
- exbivirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- exidavnemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ezabenlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fanolesomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- faralimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- faricimabUS brands: VABYSMOEU (central) brands: Vabysmo
- farletuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- farletuzumab ecteribulinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fasinumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- favezelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fazpilodemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- felzartamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fezakinumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fianlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ficlatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fidasintamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- figitumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- finotolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- firivumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fiztasovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fladilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- flanvotumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fletikumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- flotetuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fontolizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- foralumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- foravirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fremanezumabUS brands: AJOVYEU (central) brands: Ajovy
- fresolimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- frexalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- frovocimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- frunevetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fulranumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- futuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- galcanezumabUS brands: EMGALITYEU (central) brands: Emgality
- galegenimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- galiximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gancotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ganitumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gantenerumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- garadacimabUS brands: ANDEMBRYEU (central) brands: Andembry
- garivulimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gatipotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gavilimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gedivumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gefurulimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gemtuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gemtuzumab ozogamicinUS brands: MYLOTARGEU (central) brands: Mylotarg
- geptanolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gevokizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gilvetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gimsilumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ginisortamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- girentuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- girolalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glembatumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glembatumumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glenzocimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- glofitamabUS brands: COLUMVIEU (central) brands: Columvi
- golimumab
- golocdacimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gontivimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gosuranemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gratalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gremubamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- grisnilimab setaritoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gumokimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- guselkumabUS brands: TREMFYAEU (central) brands: Tremfya
- ianalumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ibalizumabUS brands: TROGARZO
- ibritumomab tiuxetanUS brands: ZEVALIN
- icrucumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- idactamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- idarucizumabUS brands: PRAXBINDEU (central) brands: Praxbind
- ieramilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ifabotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ifinatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ifinatamab deruxtecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- igovomabUS brands: none found
- iladatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- iladatuzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imalumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imaprelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imciromabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imdevimabUS brands: none found
- imgatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imsidolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- imvotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- inclacumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- indatuximab ravtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- indusatumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- indusatumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- inebilizumabUS brands: UPLIZNAEU (central) brands: Uplizna
- inezetamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- infliximab
- inolimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- inotuzumab ozogamicinUS brands: BESPONSAEU (central) brands: Besponsa
- intetumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- iparomlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ipilimumabUS brands: YERVOYEU (central) brands: Yervoy
- iratumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- isatuximabEU (central) brands: Sarclisa
- iscalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ispectamab debotansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- istiratumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- itepekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- itolizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ivicentamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ivonescimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ivuxolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ixekizumabUS brands: TALTZEU (central) brands: Taltz
- izalontamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- izenivetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- izuralimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- keliximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- labetuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- labetuzumab govitecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lacnotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lacutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ladintrevimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ladiratuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ladiratuzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lampalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lanadelumabUS brands: TAKHZYROEU (central) brands: Takhzyro
- landogrozumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- laprituximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- laprituximab emtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- larcaviximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- latozinemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lebrikizumabUS brands: EBGLYSSEU (central) brands: Ebglyss
- lecanemabEU (central) brands: Leqembi
- lemalesomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lemzoparlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lenvervimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lenzilumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lerdelimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- leronlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lesabelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lesofavumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- letaplimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- letolizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- levilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lexatumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- libivirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- licaminlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lifastuzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ligelizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ligufalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lilotomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lilotomab satetraxetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lintuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lintuzumab satetraxetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- linvoseltamabUS brands: LYNOZYFICEU (central) brands: Lynozyfic
- lirentelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lirilumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- litifilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- livmoniplimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lodapolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lodelcizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lokivetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lomtegovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- loncastuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- loncastuximab tesirineUS brands: ZYNLONTAEU (central) brands: Zynlonta
- lonigutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lonigutamab ugodotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lorigerlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lorvotuzumab mertansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- losatuxizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- losatuxizumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lucatumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lulizumab pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lumiliximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lumretuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lupartumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lupartumab amadotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lusvertikimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lutikizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- luveltamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- luveltamab tazevibulinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- maftivimabEU (central) brands: none found
- magrolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- manelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- manfidokimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mapatumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- margetuximabUS brands: MARGENZAEU (central) brands: none found
- marstacimabUS brands: HYMPAVZIEU (central) brands: Hympavzi
- maslimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- matuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mavrilimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mazorelvimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mecbotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- melrilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mepolizumabUS brands: NUCALAEU (central) brands: Nucala
- metelimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mezagitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mibavademabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- milatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- minretumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mipasetamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mipasetamab uzoptirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- miptenalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mirikizumabUS brands: OMVOHEU (central) brands: Omvoh
- miromavimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mirvetuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mirvetuximab soravtansineUS brands: ELAHEREEU (central) brands: Elahere
- mirzotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mirzotamab clezutoclaxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mitazalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mitumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- modotuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mogamulizumabUS brands: POTELIGEOEU (central) brands: Poteligeo
- monalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- morolimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mosunetuzumabEU (central) brands: Lunsumio
- motavizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- moxetumomab pasudotoxUS brands: LUMOXITI
- mupadolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- murlentamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nacolomab tafenatoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nadecnemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nadunolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- namilumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- naptumomab estafenatoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- naratuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- naratuximab emtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- narnatumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- narsoplimabUS brands: YARTEMLEAEU (central) brands: none found
- natalizumab
- navivumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- naxitamabUS brands: DANYELZAEU (central) brands: none found
- necitumumabUS brands: PORTRAZZA
- nemolizumabUS brands: NEMLUVIOEU (central) brands: Nemluvio
- nerelimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nesvacumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- netakimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nimacimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nimotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nipocalimabUS brands: IMAAVYEU (central) brands: Imaavy
- nirsevimabUS brands: BEYFORTUSEU (central) brands: Beyfortus
- nivatrotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nivolumabUS brands: OPDIVO
- nofazinlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nofetumomab merpentanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nurulimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- obexelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- obinutuzumabUS brands: GAZYVAEU (central) brands: Gazyvaro
- ocaratuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ociperlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ocrelizumabUS brands: OCREVUSEU (central) brands: Ocrevus
- odesivimabEU (central) brands: none found
- odulimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ofatumumab
- olaratumab
- oleclumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- olendalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- olinvacimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- olokizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- omalizumab
- omburtamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- omodenbamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- onartuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ongericimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ontamalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ontuxizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- onvatilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- opicinumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oportuzumab monatoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- opucolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ordesekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oregovomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- orilanolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ormutivimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- orticumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- osemitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- osocimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- otilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- otlertuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oxelumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ozanezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ozoralizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ozuriftamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ozuriftamab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pacanalotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pacmilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- palivizumabUS brands: SYNAGISEU (central) brands: Synagis
- pamrevlumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- panitumumabUS brands: VECTIBIXEU (central) brands: Vectibix
- panobacumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- parsatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pascolizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pasotuxizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pateclizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- patritumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- patritumab deruxtecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pavurutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pelgifatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pelgifatamab corixetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pembrolizumabUS brands: KEYTRUDAEU (central) brands: Keytruda
- penpulimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pepinemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- perakizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- peresolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pertuzumab
- pertuzumab zuvotolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pexelizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pidilizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pimivalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pimurutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pinatuzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pintumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pivekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pivekimab sunirineUS brands: DECNUPAZEU (central) brands: none found
- placulumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- plonmarlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- plozalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- plutavimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- polatuzumab vedotinUS brands: POLIVYEU (central) brands: Polivy
- ponezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- porgaviximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- posdinemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pozelimabUS brands: VEOPOZEU (central) brands: none found
- praluzatamab ravtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prasinezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prezalumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- priliximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pritoxaximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pritumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prolgolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pucotenlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pulocimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quavonlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quetmolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quilizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quisovalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- racotumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- radretumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rafivirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ragifilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ralpancizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ramucirumabUS brands: CYRAMZAEU (central) brands: Cyramza
- ranevetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ranibizumab
- ravagalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ravulizumabUS brands: ULTOMIRISEU (central) brands: Ultomiris
- raxibacumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- recaticimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- refanezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- regavirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- regdanvimabUS brands: none found
- relatlimab
- relfovetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- remtolumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- reosalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- reslizumabUS brands: CINQAIREU (central) brands: Cinqaero
- retifanlimabUS brands: ZYNYZEU (central) brands: Zynyz
- revdofilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rilotumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rimteravimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rinucumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ripertamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- risankizumabUS brands: SKYRIZIEU (central) brands: Skyrizi
- rituximab
- rivabazumab pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- robatumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rocatinlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- roledumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rolinsatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rolinsatamab talirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- romilkimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- romlusevimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- romosozumabUS brands: EVENITYEU (central) brands: Evenity
- rontalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rosmantuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rosnilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rosopatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rosopatamab tetraxetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rovalpituzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rovalpituzumab tesirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rovelizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rozanolixizumabUS brands: RYSTIGGOEU (central) brands: Rystiggo
- rulonilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- runimotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ruplizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sabatolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sacituzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sacituzumab govitecanUS brands: TRODELVYEU (central) brands: Trodelvy
- samalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- samrotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- samrotamab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sarilumabUS brands: KEVZARAEU (central) brands: Kevzara
- sasanlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- satralizumabUS brands: ENSPRYNGEU (central) brands: Enspryng
- satumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- secukinumabUS brands: COSENTYXEU (central) brands: Cosentyx
- selicrelumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- semorinemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- semzuvolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- serclutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- serclutamab salirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- seribantumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- serplulimabUS brands: none foundEU (central) brands: Hetronifly
- setoxaximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- setrusumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sevirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sibeprenlimabUS brands: VOYXACTEU (central) brands: none found
- sibrotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sifalimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- siltuximabUS brands: SYLVANTEU (central) brands: Sylvant
- simridarlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- simtuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sintilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- siplizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sirexatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sirtratumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sirtratumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sirukumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- socazolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sofituzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- solanezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- solitomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sonelokimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sontuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sotevtamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sotigalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sotrovimabUS brands: none found
- spartalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- spesolimabUS brands: SPEVIGOEU (central) brands: Spevigo
- stamulumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- suciraslimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sudubrilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sugemalimabUS brands: none foundEU (central) brands: Cejemly
- sulesomabUS brands: none found
- suptavumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- surzebiclimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- suvizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- suvratoxumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tabalumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tabituximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tabituximab barzuxetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tadocizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tafasitamabUS brands: MONJUVIEU (central) brands: Minjuvi
- tafolecimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tagitanlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- talacotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- talizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- talquetamabUS brands: TALVEYEU (central) brands: Talvey
- tamgiblimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tamrintamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tamrintamab pamozirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tamtuvetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tanezumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- taplitumomab paptoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tarcocimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tarcocimab tedromerNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tarextumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tarlatamabUS brands: IMDELLTRAEU (central) brands: Imdylltra
- tavolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tebotelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tecaginlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- teclistamabUS brands: TECVAYLIEU (central) brands: Tecvayli
- tefibazumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telazorlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telimomab aritoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telisotuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telisotuzumab vedotinUS brands: EMRELISEU (central) brands: none found
- temelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tenatumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- teneliximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- teplizumabUS brands: TZIELDEU (central) brands: Teizeild
- tepoditamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- teprotumumabUS brands: TEPEZZAEU (central) brands: Tepezza
- teropavimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tesidolumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tesnatilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tezepelumabUS brands: TEZSPIREEU (central) brands: Tezspire
- tibulizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tidutamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tifcemalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tigatuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tilavonemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tildrakizumabUS brands: ILUMYAEU (central) brands: Ilumetri
- tilogotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tilvestamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- timigutuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- timolumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tinurilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tiragolumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tirnovetmabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tislelizumabUS brands: TEVIMBRA
- tisotumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tisotumab vedotinUS brands: TIVDAKEU (central) brands: Tivdak
- tixagevimabUS brands: none found
- tocilizumab
- tomaralimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tomuzotuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- toralizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- toripalimabUS brands: LOQTORZIEU (central) brands: Loqtorzi
- torudokimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tosatoxumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tositumomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tovetumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tozorakimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tralokinumabUS brands: ADBRYEU (central) brands: Adtralza
- trastuzumab
- trastuzumab betaNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trastuzumab botidotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trastuzumab corixetanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trastuzumab deruxtecanUS brands: ENHERTUFDA writes it FAM-TRASTUZUMAB DERUXTECANEU (central) brands: Enhertu
- trastuzumab duocarmazineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trastuzumab emtansineUS brands: KADCYLAFDA writes it ADO-TRASTUZUMAB EMTANSINEEU (central) brands: Kadcyla
- trastuzumab imbotolimodNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trastuzumab rezetecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trastuzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tregalizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tremelimumabUS brands: IMJUDO
- trevogrumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trinbelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trontinemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tucotuzumab celmoleukinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tusamitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tusamitamab ravtansineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tuvirumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tuvonralimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ubamatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ublituximabUS brands: BRIUMVIEU (central) brands: Briumvi
- ulenistamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- uliledlimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ulocuplumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- unasnemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- upanovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- urabrelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- urelumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ustekinumab
- utomilumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vadastuximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vadastuximab talirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vandortuzumab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vantictumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vanucizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vapaliximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- varisacumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- varlilumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vatelizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vedolizumabUS brands: ENTYVIOEU (central) brands: Entyvio
- veltuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vepalimomabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vepsitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vesencumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vibecotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vibostolimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vilobelimabUS brands: none foundEU (central) brands: Gohibic
- visilizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vixarelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vixtimotamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vobarilizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vobramitamab duocarmazineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vofatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- volagidemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- volociximabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vonlerolizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vopratelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vorsetuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vorsetuzumab mafodotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- votumumabUS brands: none found
- voxalatamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vudalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vulinacimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vunakizumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- xeligekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- xentuzumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zagotenemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zalifrelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zalutumumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zamerovimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zampilimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zanidatamab zovodotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zanolimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zansecimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zelminemabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zeluvalimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zenocutuzumabUS brands: BIZENGRIEU (central) brands: none found
- zilovertamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zilovertamab vedotinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ziltivekimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zimberelimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zinlirvimabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ziralimumabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zolbetuximabUS brands: VYLOYEU (central) brands: Vyloy
- zolimomab aritoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zuberitamabNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
atinumab
Listed INNCarries the WHO stem -mab
- -mabend of the nameWHO lists it hereWHO definition: monoclonal antibodies (previous naming scheme)
“atinumab” is an INN that WHO lists under -mab in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -mab (Part II B) and the 831 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.